Related Experiment Video

Updated: Dec 16, 2025

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.6K

Practical management of C3 glomerulopathy and Ig-mediated MPGN: facts and uncertainties

Fadi Fakhouri1, Moglie Le Quintrec2, Véronique Frémeaux-Bacchi3

  • 1Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Kidney International
|July 6, 2020
PubMed

Insights

C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis remain poorly understood, hindering effective patient management. This review addresses persistent uncertainties in their pathophysiology, classification, and treatment efficacy.

Area of Science:

  • Nephrology
  • Immunopathology
  • Glomerular Diseases

Background:

  • Recent research has focused on C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis.
  • Despite extensive data, significant knowledge gaps persist regarding these rare kidney diseases.

Purpose of the Study:

  • To review and discuss the persistent uncertainties surrounding C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis.
  • To analyze the impact of these uncertainties on current clinical management strategies for patients.

Main Methods:

  • Comprehensive literature review of experimental and clinical studies.
  • Synthesis of existing data to identify and discuss key areas of uncertainty.
  • Analysis of the implications for patient care and therapeutic approaches.

Main Results:

  • Persistent uncertainties exist in pathophysiology, classification, and clinical course.
  • The relevance of biomarkers and pathology findings requires further clarification.
  • Assessment of current therapy efficacy remains challenging due to limited data.

Conclusions:

  • Addressing these uncertainties is crucial for improving the clinical management of C3 glomerulopathy and Ig-mediated membranoproliferative glomerulonephritis.
  • Further research is needed to refine diagnostic criteria, prognostic markers, and therapeutic strategies.

Keywords:
C3 glomerulopathyIg-mediated membranoproliferative glomerulonephritiscomplement

More Related Videos

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells04:46

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells

Published on: March 7, 2025

796
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

761

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
254
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
125
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
201
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
207
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
870
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K